Q&A

Conference Coverage
Conference Coverage
06/03/2024
Yuriko Fukuta, MD, PhD
Yuriko Fukuta, MD, PhD, discusses her research team's study, which evaluated the risk factors associated with post-COVID conditions. She presented her findings at IDWeek 2023 in Boston, MA.
06/03/2024
expert Q&A
expert Q&A
05/31/2024

Joseph Magagnoli, MS

Joseph Magagnoli, MS
Acetylcholinesterase inhibitors are frequently used in the treatment of Alzheimer disease due to their anti-inflammatory effects. But what is the potential of this class of medications to also impact the...
05/31/2024
Expert Q&A
Expert Q&A
05/11/2024
In this Q and A, Chief Investigator of the EMPA-KIDNEY trial, William Herrington, MA, MBBS, MD, answers questions about the results of the trial, including the effects of the SGLT2 inhibitor, empagliflozin,...
05/11/2024
expert Q&A
expert Q&A
05/02/2024
Melissa E. Badowski, PharmD, MPH
In this expert interview, Melissa E. Badowski, PharmD, MPH, provides an overview of her presentation at IDWeek 2023 titled, "Guideline Adherence to Hepatitis B Virus Screening and Vaccination in Patients...
05/02/2024
expert Q&A
expert Q&A
04/13/2024

James W. Antoon, MD, PhD, MPH

James W. Antoon, MD, PhD, MPH
In this expert Q and A, James W. Antoon, MD, PhD, MPH, discusses the results of his team's recent study examining the rate of neuropsychiatric events associated with influenza infection and treatment in...
04/13/2024
expert Q&A
expert Q&A
04/04/2024
In this expert Q&A, Mats Enlund, MD, PhD, discusses his team's study that adds to the growing literature on the impact of general anesthesia choice on overall survival among patients undergoing breast...
04/04/2024
Expert Q&A
steven e nissen, md
Expert Q&A
03/29/2024
Steven E. Nissen, MD, lead author of the study “Bempedoic Acid And Cardiovascular Outcomes In Statin-Intolerant Patients,” answers questions on the importance of his team’s research on bempedoic acid, how...
03/29/2024
expert Q&A
expert Q&A
03/25/2024

Peter G. Jacobs, PhD

Peter G. Jacobs, PhD
In this Q&A, study author Peter G. Jacobs, PhD, discusses the results of his team’s recent study examining the potential of combining wearable fitness sensor data with automated insulin delivery systems...
03/25/2024
Expert Q&A
Expert Q&A
03/23/2024
James F. List, MD, PhD
Based on findings from the Phase 3 A DUE study, Janssen Research & Development, LLC recently submitted a New Drug Application to the FDA seeking approval of an investigational once-daily, single-tablet...
03/23/2024
Expert Q&A
Expert Q&A
03/18/2024
The FDA approved the use of Pfizer’s bivalent prefusion f vaccine in older adults to protect against respiratory syncytial virus. A Pfizer spokesperson answered questions about the study that helped lead to...
03/18/2024